You are here

  • Home
  • Archive
  • Volume 91, Issue 6
  • A paclitaxel coated stent used for in-stent restenosis within a sirolimus coated stent fails to protect against recurrent restenosis

Article Text

Article menu
Download PDFPDF
Miscellanea
A paclitaxel coated stent used for in-stent restenosis within a sirolimus coated stent fails to protect against recurrent restenosis
  1. A D Bainbridge,
  2. D Muir,
  3. F Fath-Ordoubadi
  1. t.bainbridge@virgin.net

https://doi.org/10.1136/hrt.2004.044552

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The optimal approach to in-stent restenosis (ISR) within a drug eluting stent (DES) remains uncertain. The Rotterdam research registry reported a zero major adverse cardiac event (MACE) rate at a median of 131 days in 10 patients …

    View Full Text